Background: Predictors of outcome in lateral epicondylalgia, which is mainly characterized as a mechanical hyperalgesia, are largely limited to sociodemographic and symptomatic factors. Quantitative sensory testing is used to study altered pain processing in various chronic pain conditions and may be of prognostic relevance.
L ateral epicondylalgia (LE) or tennis elbow is a common musculoskeletal condition with a population prevalence of 1% to 4%. 1, 2 Considerable variability is found in the literature on its prognosis, with typical durations ranging from 6 months to years, and differing opinions on the likelihood of recurrence. 3 The ability to predict which patients will develop chronic pain is important so that appropriate early management can be targeted to these patients. Investigation of prognostic factors associated with LE has previously focused on sociodemographic and symptomatic factors, many of which have not demonstrated consistency across independent studies 3 or are not readily amenable to secondary and tertiary intervention. 4 The role of other physical and psychological factors on the prognosis of LE has not been addressed.
Over the last couple of decades, quantitative sensory testing (QST) has sometimes been used as a potential clinical method for diagnosis and monitoring of pain processing and its alterations in patients with chronic pain. 5 A common technique involves application of noxious stimuli, such as mechanical or thermal, to the patient under standardized conditions and deriving the threshold for the transition to pain (ie, the pain threshold), as well as the tolerance and the intensity of the noxious stimulation. Cross-sectional evaluation of QST in patients with LE has revealed widespread mechanical hyperalgesia, [6] [7] [8] and bilateral cold hyperalgesia in unilateral LE, notably in a subpopulation of severe LE. 8, 9 The presence of generalized hyperalgesia, evident in a large number of other chronic pain conditions, including whiplash, 10 back pain, 11 fibromyalgia, 12 and patellofemoral pain syndrome, 13 is cited as a sign of supraspinal central senitization. 5 Preoperative hyperalgesia has been shown to increase the risk of subsequent postoperative chronic pain, 5 while the predictive capacity of cold pain 4, 14 and pressure pain thresholds (PPTs) 15 have been demonstrated after whiplash injury. To date, no studies have evaluated the prognostic capacity of QST measures on pain and disability in patients with LE. In addition, serial assessment of mechanical hyperalgesia, a characteristic feature of LE, 8 might be a clinically useful method of monitoring development of chronic pain, hence study of factors associated with its persistence is warranted.
There is also budding interest in psychological factors in chronic musculoskeletal conditions. Fear of movement or injury has been identified as a predictor of disability in acute and chronic low back pain 16 and arm, neck, and shoulder pain. 17 Depression commonly co-occurs with chronic pain and may affect a patients' prognosis and hinder recovery. 18 Higher levels of depression and anxiety were associated with pain and disability in a small study of LE, 19 although this was not substantiated in a larger study. 8 Simultaneous measurement of QST and psychological factors may allow exploration of the relative predictive capacity of these possibly interacting factors. 20 This study aimed to investigate the predictive capacity of early physical and psychological measures on short-term and long-term outcomes of pain and disability and mechanical hyperalgesia at the affected elbow.
METHODS

Study Design
This was a post hoc analysis of a previously reported 12-month prospective study of the clinical efficacy of corticosteroid injection and physiotherapy interventions in 165 participants with LE. 21, 22 The methodology and results of this trial are presented in detail elsewhere. 21, 22 In summary, consenting patients were randomly assigned to either a placebo intervention (described below) or 1 of 3 conservative interventions (corticosteroid injection, physiotherapy, or their combination). Because of significant effects of the active treatments on outcomes, only participants randomized to placebo (n = 41) were included in the current prognostic analysis. Participants attended the research unit to complete all questionnaires and assessments by a blinded outcome assessor. Ethical approval was granted by The University of Queensland Medical Research Ethics Committee and all participants provided written informed consent.
Participants
Trial participants were recruited through community advertisement from Brisbane, Australia between August 2008 and May 2010, and were screened for eligibility through telephone interview and physical examination. Inclusion criteria were unilateral lateral elbow pain >6 weeks duration, over the lateral humeral epicondyle of severity >30 on a 100 mm visual analogue scale, provoked by at least 2 of: gripping, palpation, resisted wrist or middle finger extension, or stretching of forearm extensor muscles with reduced pain-free grip. Exclusion criteria were injection (preceding 6 mo); course of physiotherapy (preceding 3 mo); concomitant neck or other arm pain necessitating treatment or preventing participation in usual work or recreational activities (preceding 6 mo); symptoms suggesting radicular, neurological, or systemic arthritic conditions; pregnancy; breastfeeding; or contraindication to injection.
Placebo-assigned participants received a single, blinded injection of a negligible volume (0.5 mL) isotonic (0.9%) saline within 10 days of randomization. Participants received standardized advice and could use an analgesic or anti-inflammatory medication, heat or cold packs, or braces as needed, but were discouraged from seeking treatments other than those assigned during the 1-year follow-up period.
Measures
The 2 outcome measures (dependent variables) in this study were pain and disability, as measured by the Patientrated Tennis Elbow Evaluation (PRTEE) and mechanical hyperalgesia, as measured by PPT over the affected lateral elbow. The independent variables were measures of both physical and psychological impairment recorded at baseline as outlined below. Sex and duration were also included as these have been highlighted as potential predictors of outcome. [23] [24] [25] 
Pain and Disability
The PRTEE is a reliable, reproducible, and sensitive instrument for assessment of pain and disability in LE. 26, 27 It has been found to be at least as sensitive to change as other measurement tools, and is proposed as the standard primary outcome measure in research of LE. 26 Items are scored on a series of 10-point Likert scales, with 5 items used to assess pain and 10 items used to assess function. Pain and disability subscales contribute equally to the overall score, ranging from 0 (no pain or disability) to 100 (worst pain or disability).
QST
Pressure and cold pain thresholds were measured over the affected lateral elbow, using established protocols. 22, 28 Previous studies have confirmed the reliability of these measures (ICCs > 0.86). 6, 8 PPT was measured using a digital pressure algometer (Somedic AB, Farsta, Sweden), with a probe size 1 cm 2 , applied perpendicular to the tissues at the tendinous origin of the wrist extensor muscles, at a rate of 40 kPa/s. To capture an individual's pain threshold, participants were instructed to indicate when the sensation changed from a comfortable sensation to the first onset of pain. Cold pain threshold was measured using the Thermotest system (Somedic AB, Farsta, Sweden). From a baseline temperature of 301C, the thermode was decreased at a rate of 11C/s until the first sensation of pain was perceived or a minimum cutoff temperature of 51C was reached. Each QST stimulus was applied 3 times and the mean value was used for all analyses.
Pain-Free Grip
Pain-free grip is established as a convenient and reliable (ICC > 0.97) assessment tool, which correlates more strongly with disability and perceived improvement than maximal grip strength in LE populations. [29] [30] [31] It was measured on the affected arm using a digital grip dynamometer with variable hand position (MIE, Medical Research, UK). The participant was positioned in supine position with the arm in relaxed extension and forearm in pronation, such that the palm of the hand faced down on the plinth. Participants squeezed the dynamometer at a consistent rate and stopped once the instant pain was experienced. Three recordings were taken and the mean value was used in the analyses.
Psychological Measures
The Hospital Anxiety and Depression Scale is a short self-assessment questionnaire that measures anxiety and depression, and has been demonstrated to be an appropriate measure in musculoskeletal pain. 32 It consists of 14 items rated on 4-point scales with a total score ranging from 0 to 42, greater scores indicating greater anxiety and depression. The Tampa Scale of Kinesiphobia was used to quantify kinesiophobia, defined as an irrational, and debilitating fear of physical movement and activity resulting from a feeling of vulnerability to painful injury or reinjury. 33 The scale is based on the model of fear of avoidance, fear of work-related activities, fear of movement, and fear of reinjury. 33 The 11-item questionnaire, which has been validated in upper extremity disorders, consists of 11 items rated on 4-point Likert scales with a total score ranging from 11 to 44, greater scores indicating greater kinesiophobia. 34 
Data Analysis
Statistical analyses were performed by intention to treat using SPSS (version 20.0). Baseline data for each potential prognostic variable were presented as means and SDs for continuous data, and numbers and percentages for categorical data. The independent t tests and the Pearson w 2 tests were used to evaluate whether continuous and categorical baseline variables differed between participants randomized to placebo, and those randomized to the 3 active interventions. Descriptive statistics were used to describe the condition at short-term and long-term follow-up.
Potential prognostic variables, including baseline values, were entered into multivariate backward stepwise linear regression analyses for each of the outcomes of PRTEE and PPT at both 2 and 12 months, in a manner consistent with previous study. 35 Variables with the highest P values were removed one at a time, until all remaining variables were significant at P < 0.10. Associations within each multivariate model were regarded as significant at Pr0.05. The strength of the predictive ability of identified factors in each multivariate model was evaluated by unstandardized regression coefficients (b) with 95% confidence intervals. Standardized regression coefficients were also reported to determine which of the independent variables had a greater effect on the dependent variable. Overall performance of the final models was evaluated with Nagelkerke R 2 , which estimates the percentage of explained variation of the model.
RESULTS
Of the 41 participants assigned to placebo, 1 participant did not receive the saline injection because of a feeling of having recovered. Baseline demographic and symptomatic characteristics were comparable between participants assigned to placebo (n = 41) and the overall randomized controlled trial population (n = 165) ( Table 1 ). All placeboassigned participants were followed-up at 2 months and 40/41 (98%) could be contacted at 1 year. During the 1-year followup, oral analgesic or nonsteroidal anti-inflammatory medication was used by 39% (16/41) of participants, whereas 15% (6/41) sought additional medical consultations.
Predictors of Pain and Disability
Mean PRTEE scores improved from 41.6 ± 14.5 at baseline to 23.2 ± 13.5 at 2 months and 5.2 ± 11.4 at 12 months. The multivariate model for PRTEE at 2 months revealed that greater baseline pain and disability (b = 0.39; 95% CI, 0.15-0.62; P = 0.002) and greater cold hyperalgesia (b = 0.77; 95% CI, 0.21-1.33; P = 0.008) were significantly associated with greater pain and disability ( Table 2 ). The model explained 35% of the total variance, with baseline PRTEE having greater relative effect on the outcome. The 12-month multivariate model found that greater cold hyperalgesia (b = 0.61; 95% CI, 0.05-1.17; P = 0.034) was the only factor significantly associated with greater pain and disability, explaining 9% of the total variance ( Table 2 ).
Predictors of Mechanical Hyperalgesia
Mean PPT (kPa) at the affected elbow improved from 273.5 ± 130.5 at baseline to 351.4 ± 140.7 at 2 months and 462.1 ± 199.7 at 12 months. Multivariate analysis (Table 3) revealed greater hyperalgesia at 2 months in females (b = À149.83; 95% CI, À 222.38 to À77.28; P < 0.001) with greater cold hyperalgesia (b = À6.19; 95% CI, À 11.98 to À0.39; P = 0.037). The model explained 46% of the total variance, with female sex having a greater relative effect on the outcome. The 12-month multivariate model (Table 3) showed female sex (b = À177.98; 95% CI, À285.7 to À70.26; P = 0.002) and greater cold hyperalgesia (b = À8.45; 95% CI, À16.8 to À 0.09; P = 0.048), as well as baseline PPT (b = 0.39; 95% CI, 0.01-0.77; P = 0.046) were independent predictors of greater long-term mechanical hyperalgesia. This model explained 50% of the total variance. Of these independent predictors, female sex had the greatest effect on PPT, followed by cold pain threshold, with baseline PPT values having the least prognostic influence.
DISCUSSION
This exploratory study of 41 placebo-assigned participants with unilateral LE is the first to show that the presence of cold hyperalgesia is associated with greater short-term and long-term pain and disability, as well as hyperalgesia to mechanical stimuli. In combination with baseline PRTEE scores, it explained approximately one third of the variance in pain and disability at 2 months. In the long term, it was the only significant predictor of pain and disability, although explained only a small proportion (9%) of the variability. Secondly, the results demonstrate that mechanical hyperalgesia persists at the affected elbow in women with cold hyperalgesia, independent of baseline PPT values. At 1 year, over half the variability in mechanical hyperalgesia could be explained by baseline cold hyperalgesia and sex.
Cold hyperalgesia is emerging as an important indicator of poorer recovery in other musculoskeletal conditions such as whiplash. 4, 14, 36 Cold pain threshold of >131C was found to increase the risk of developing chronic moderate to severe pain and disability by 26-fold in individuals with whiplash (odds ratio; 95% CI, 5.0-139.1). 37 We previously reported mean cold pain thresholds over the affected elbow of 13.71C in LE participants with severe pain and disability (PRTEE > 54), which was significantly greater than a healthy control population (mean 7.61C). 8 Only data from the placebo group were analyzed in this prognostic evaluation. No baseline differences were found between placebo and intervention groups.
Values are mean ± SD or count (%). HADS indicates Hospital Anxiety and Depression Scale; PRTEE, Patient-rated Tennis Elbow Evaluation; TSK, Tampa Scale of Kinesiophobia.
The mechanisms underlying cold hyperalgesia after injury are only partially understood, but may include altered processing by second-order spinal cord sensory neurons or by changes in ion channel expression at peripheral coldspecific fiber terminals. 38 Considerable variability is found on review of studies investigating prognostic factors for LE, with methodological weaknesses and low sample sizes likely contributing to this. 3 Consistent with earlier studies of LE, 23 and other musculoskeletal conditions, 39 we found baseline scores to predict short-term recovery of pain and disability. However, we did not find an association between duration and pain and disability, as was found by other studies of LE. 23, 40 Unlike 2 of these studies, 25, 40 we excluded patients with symptoms <6 weeks in duration, hence we cannot draw conclusions on the prognosis of acute LE. In our study population, psychological factors did not significantly influence either pain and disability or mechanical hyperalgesia at the elbow.
Although significantly correlated, pain and disability and mechanical hyperalgesia likely represent different aspects of the health condition of LE, the latter proposed to be a composite of physiological and psychological features of the patient and the health problem, mediated by social aspects. 15 In this study, females showed greater mechanical hyperalgesia, which is consistent with findings from pain-free populations, 24 whereas pain and disability were comparable between the sexes. Of note, only a small proportion (9%) of the variability in long-term pain and disability was explained by the prognostic factors examined here. Despite a much larger sample size (n = 349), Smidt et al 23 also found the final set of predictors accounted for a low proportion (11%) of the variability in pain severity at 1 year. As such there may be other important predictive Standardized coefficient and unstandardized regression coefficient (b) and its 95% confidence interval (CI). b positive refers to more pain and disability per unit potential prognostic indicator and b negative indicates less pain and disability per unit potential prognostic indicator.
Adjusted factors that were not measured in these studies, or alternatively it might not be possible to predict outcomes after 1 year for LE. We evaluated the prognostic capacity of QST measured at the affected elbow, although investigation of hyperalgesia at widespread sites or using other measures of central hypersensitivity, such as the nociceptive withdrawal reflex, may have allowed greater insight and speculation of the mechanisms involved in chronic pain development.
Strengths and Limitations
The major strengths of this study are its methodological rigor, including high retention of participants and use of valid and reliable psychometric instruments to study pain processing combined with a psychological perspective. However, given the relatively small number of participants in relation to the statistical requirements of prognostic investigation, this study should be considered exploratory. This study represents a secondary analysis of data from a randomized controlled trial, where predictive models were examined only in placebo-assigned individuals. While avoiding confounding associated with significant effects of corticosteroid injection and physiotherapy, it should be acknowledged that administration of a blinded placebo injection might cause treatment expectations. 41 However, recovery profiles were remarkably similar to previous studies in which 27% 42 and 32% 43 of patients assigned to a waitand-see policy reported being completely recovered or much improved after 6 weeks, compared with 29% of patients assigned to placebo at 8 weeks in our study. Similar recovery was also seen at 1 year, with 92.5% of placebo-injected patients and 87% of those assigned to a wait-and-see approach 44 being completely recovered or much improved. Nonetheless, results should be viewed as preliminary until replication in other LE populations is undertaken.
Implications for Clinical Practice and Future Research
Although obviously in need of further confirmation, the results provide preliminary suggestions for clinical practice and future research. Assessment of cold pain thresholds may assist early identification of altered pain processing that is associated with higher risk for chronic pain development. The presence of cold hyperalgesia, particularly in LE patients with greater pain and disability, warrants early intervention targeted toward effective control of nociceptive input, and for example, might distinguish those who may benefit from more centrally acting analgesics. Considerable research is needed before the clinical utility of this measure can be realized. In addition to validation of these findings, further research is needed to determine thresholds for cold hyperalgesia and explore whether the described changes in pain processing recover or persist over time.
CONCLUSIONS
Assessment of cold pain thresholds might be a valuable clinical tool to help identify patients with LE at risk of poorer prognosis. This study sheds early insight into the mechanisms underlying the development of chronic pain associated with LE and may provide direction for mechanism-based therapeutic and preventative approaches.
